comparemela.com

Page 30 - Cardiff Oncology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology company, developing new precision medicine treatment options for cancer.

Cardiff Oncology to Present at the B Riley Securities 2022 Oncology Conference

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology company, developing new precision medicine treatment options for cancer.

vimarsana © 2020. All Rights Reserved.